Cyclooxygenases: From Prostaglandin Synthesis to Innovative Therapies for Inflammation

Area of Science:

• Biochemistry
• Pharmacology
• Oral Medicine

Background:

• Cyclooxygenases (COX) are key enzymes in prostaglandin synthesis, crucial for inflammation.
• Non-steroidal anti-inflammatory drugs (NSAIDs) are common but have significant side effects, leading to market withdrawals.
• Selective COX-2 inhibitors are sought for safer anti-inflammatory therapies.

Purpose of the Study:

• To review diseases linked to cyclooxygenase enzyme malfunction.
• To examine current therapies and explore novel drug discovery avenues for COX inhibition.
• To analyze pharmaceutical products for COX inhibition efficacy and side effects.

Main Methods:

• Literature review of cyclooxygenase enzyme function and related diseases.
• Analysis of current therapeutic strategies, including NSAIDs and newer inhibitors.
• Evaluation of pharmaceutical products targeting COX enzymes, considering history, efficacy, and safety profiles.

Main Results:

• NSAIDs, while effective, are associated with severe adverse effects.
• Cyclooxygenase enzymes are implicated in various physiological and pathological processes, including oral tissue disorders like periodontitis, pulpitis, and oral cancer.
• Emerging COX inhibitors, including dietary changes and natural supplements, show potential for improved safety and efficacy.

Conclusions:

• Cyclooxygenase enzyme malfunction underlies numerous diseases, necessitating safer therapeutic interventions.
• Current NSAIDs pose significant risks, driving the need for alternative treatments.
• Natural compounds and dietary modifications represent promising avenues for developing safer and more effective COX inhibitors.